[
  {
    "ts": null,
    "headline": "Eli Lilly's (NYSE:LLY) Dividend Will Be Increased To $1.50",
    "summary": "The board of Eli Lilly and Company ( NYSE:LLY ) has announced that it will be paying its dividend of $1.50 on the 10th...",
    "url": "https://finnhub.io/api/news?id=957d801740c2ed74df138fca744b7d83a1024d5cb4e05e3c8e35cba5ad9ce4e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735992298,
      "headline": "Eli Lilly's (NYSE:LLY) Dividend Will Be Increased To $1.50",
      "id": 132270050,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/1b6847ee48493a5698212be177362a15",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The board of Eli Lilly and Company ( NYSE:LLY ) has announced that it will be paying its dividend of $1.50 on the 10th...",
      "url": "https://finnhub.io/api/news?id=957d801740c2ed74df138fca744b7d83a1024d5cb4e05e3c8e35cba5ad9ce4e2"
    }
  },
  {
    "ts": null,
    "headline": "Prediction: These 3 Healthcare Stocks Will Soar in 2025",
    "summary": "Here's why they chose Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Summit Therapeutics (NASDAQ: SMMT).  David Jagielski (Amgen): Shares of Amgen started crashing in late November following the release of data from a phase 2 clinical trial for its weight loss candidate, MariTide.",
    "url": "https://finnhub.io/api/news?id=1c8954e87e40b08cccb040ec3b670cc0f62d88f6b2426631d3df84521d6aaeb5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735991280,
      "headline": "Prediction: These 3 Healthcare Stocks Will Soar in 2025",
      "id": 132268525,
      "image": "https://g.foolcdn.com/editorial/images/802692/stock-chart-rocket.jpg",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Here's why they chose Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Summit Therapeutics (NASDAQ: SMMT).  David Jagielski (Amgen): Shares of Amgen started crashing in late November following the release of data from a phase 2 clinical trial for its weight loss candidate, MariTide.",
      "url": "https://finnhub.io/api/news?id=1c8954e87e40b08cccb040ec3b670cc0f62d88f6b2426631d3df84521d6aaeb5"
    }
  }
]